Oct 3, 20221 min readEducating Your Patients on IMBRUVICA Treatment for CLL/SLL: A Case-based Approach ~ Tomorrow night! Click to Register Full flyer info:Octoberinvite.pdfDownload PDF • 330KB
The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3
Comments